VanEck Pharmaceutical ETF Rating $102.60 +0.48 (+0.47%) As of 03:59 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.59Holdings in PPH have an aggregate rating of Moderate Buy based on 341 analyst ratings issued in the past year covering 22 companies (84.7% of the portfolio).PPH Aggregate Price Target$102.60High Prediction$102.60Average Prediction$102.60Low Prediction$102.60Holdings in PPH have an aggregate price target of $102.60 and a range of $102.60 to $102.60 covering 22 companies (84.7% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings20.02%LLYEli Lilly and Company$989.02+2.2%4.8771 of 5 stars2.87$1,217.59 23.1%30Trending NewsEarnings ReportDividend AnnouncementAnalyst Upgrade9.31%MRKMerck & Co., Inc.$113.21+0.1%4.8152 of 5 stars2.68$128.18 13.2%19Trending NewsEarnings Report5.91%NVONovo Nordisk A/S$44.87+1.1%4.7695 of 5 stars2.13$65.56 46.1%23Trending NewsUpcoming Earnings4.98%PFEPfizer$26.42+0.5%3.9753 of 5 stars2.23$28.74 8.8%22Trending NewsEarnings Report4.48%BMYBristol Myers Squibb$56.94-0.8%4.7086 of 5 stars2.37$61.31 7.7%19Trending NewsEarnings Report4.33%SNYSanofi$43.36+0.0%3.9858 of 5 stars2.40$51.00 17.6%154.32%GSKGSK$50.37-1.0%3.595 of 5 stars1.90$53.00 5.2%10Dividend Cut4.07%JNJJohnson & Johnson$225.59+0.6%4.921 of 5 stars2.67$252.48 11.9%27Trending News4.04%MCKMcKesson$800.99-0.8%4.8889 of 5 stars2.82$972.27 21.4%17Upcoming EarningsAnalyst Upgrade4.01%ABBVAbbVie$206.12-1.0%4.909 of 5 stars2.85$252.90 22.7%26Trending NewsEarnings Report3.67%CORCencora$305.89+0.7%4.8554 of 5 stars2.80$398.17 30.2%15Positive NewsUpcoming Earnings3.38%TEVATeva Pharmaceutical Industries$35.86+1.5%4.4755 of 5 stars2.80$41.56 15.9%10Trending NewsEarnings ReportAnalyst DowngradeInsider Trade3.37%ZTSZoetis$112.60-0.1%4.9545 of 5 stars2.40$151.75 34.8%15Positive NewsUpcoming EarningsAnalyst Downgrade3.02%HLNHaleon$9.18-0.7%4.328 of 5 stars2.78$12.33 34.3%92.86%TAKTakeda Pharmaceutical$16.54-0.1%0.9931 of 5 stars2.504News Coverage1.03%VTRSViatris$15.53+2.2%1.4407 of 5 stars2.43$14.67 -5.6%7News CoverageUpcoming EarningsDividend AnnouncementGap Down0.90%JAZZJazz Pharmaceuticals$212.26+2.0%3.4469 of 5 stars2.83$216.87 2.2%18Positive News0.69%AXSMAxsome Therapeutics$223.06-0.3%3.17 of 5 stars2.90$251.89 12.9%21Trending NewsEarnings ReportAnalyst Forecast0.34%ELANElanco Animal Health$23.05+2.4%3.2739 of 5 stars2.77$27.90 21.0%13Upcoming Earnings0.29%CORTCorcept Therapeutics$51.37-0.5%4.3822 of 5 stars2.50$74.67 45.4%8Earnings ReportAnalyst ForecastAnalyst Revision0.22%OGNOrganon & Co.$13.34+0.6%2.5853 of 5 stars1.57$11.40 -14.5%7Earnings ReportUpcoming EarningsDividend Announcement0.08%PRGOPerrigo$11.60+1.9%4.6341 of 5 stars2.00$19.33 66.6%6Upcoming EarningsDividend Announcement This page (NASDAQ:PPH) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredThe $1.75T "Backdoor" ticker (NOT Starlink)When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...Behind the Markets | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
